Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism RUNX1 antagonists(RUNX family transcription factor 1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC71H88Cl2N24O11 |
InChIKeyKEMUNUGWVPYFER-UHFFFAOYSA-N |
CAS Registry2177285-35-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Small Cell Lung Cancer | Preclinical | JP | 27 May 2024 |